RxDoctor Payments DataLook up a doctor →

Rachael Murphy, MD

Internal Medicine · Covington, LANPI 1528039781

Payments from drug & device makers

$268,203in general payments, 2019–2025

Across 730 payments — averaging $367.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$114K
  • Modernatx, Inc.$94K
  • Swing Therapeutics, Inc.$30K
  • AstraZeneca$14K
  • BD$5K
  • AbbVie$2K
  • plus $10K from 54 others
$101,737in research payments, 2019–2025

Across 5 payments — averaging $20,347 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$90K
  • BD$12K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly3$113,599
Modernatx, Inc.24$94,244
Swing Therapeutics, Inc.9$29,583
AstraZeneca37$14,292
BD1$4,690
AbbVie(2 entities)117$1,939
Novo Nordisk76$1,225
Lilly USA, LLC57$938
Sunovion Pharmaceuticals Inc.36$745
GSK46$734
Pfizer41$673
Supernus Pharmaceuticals, Inc.23$573
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC31$470
Takeda Pharmaceuticals U.S.A., Inc.21$391
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)19$377
Astellas Pharma US Inc15$343
Boehringer Ingelheim18$309
Noven Therapeutics, LLC14$271
Amneal Pharmaceuticals LLC14$260
Axsome Therapeutics, Inc.10$220
Amgen(2 entities)12$203
Alkermes, Inc.10$201
Jazz Pharmaceuticals Inc.8$189
Tolmar, Inc.7$146
Novartis6$113
Johnson & Johnson6$100
MDD US Operations, LLC2$98
Indivior Inc.4$95
Kowa Pharmaceuticals America, Inc.5$94
Idorsia Pharmaceuticals US Inc5$86
Intra-sana Laboratories4$83
Shield Therapeutics Inc4$71
Boston Scientific3$63
Gilead3$59
Eisai Inc.3$56
Alfasigma USA, Inc.3$48
Otsuka America Pharmaceutical, Inc.2$39
Bayer2$38
Orexo US, Inc.1$36
Sanofi1$36
Kyowa Kirin, Inc.2$35
Acerus Pharmaceuticals Corporation2$35
Abbott2$33
Corcept Therapeutics2$33
Sumitomo Pharma America, Inc.3$30
Dexcom, Inc.1$26
Exact Sciences1$24
Philips North America LLC1$22
Smith+Nephew1$21
Biohaven Pharmaceutical Holding Company Ltd.1$21
Antares Pharma, Inc.1$21
Shire North American Group Inc1$20
Vertical Pharmaceuticals, LLC1$20
Renalytix AI, Inc.1$19
Lundbeck LLC1$19
Adlon Therapeutics L.p.1$18
Ironwood Pharmaceuticals, Inc1$17
Qiagen, LLC1$16
Phathom Pharmaceuticals, Inc.1$15
Acella Pharmaceuticals, LLC1$15

How this compares

$268,203 in reported general payments places this provider in the 95th percentile of 1,528 internal medicine providers in Louisiana.

See all internal medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$90,338
Medicare patients
87
Services billed
1,375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Covington

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →